GlassScriptPhysician profile
Mark C Yagodich
NPI 1831107325
$1,181.71
in general payments reported to CMS, 2019-2025
16 companies · $449 in 2025
The $449 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $48.31 · 2020: $50.43 · 2021: $24.73 · 2022: $16.91 · 2023: $279 · 2024: $314 · 2025: $449.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,041.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,041.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $289.37 | 2024-2025 | Grafix Pl, Stravix, Oasis |
| Averitas Pharma INC. | $277.97 | 2023-2025 | Qutenza |
| Stability Biologics, LLC | $135.00 | 2025 | |
| Sebela Pharmaceuticals INC. | $98.86 | 2020-2023 | Naftin |
| Podimetrics, INC. | $69.76 | 2025 | Smartmat |
| Paratek Pharmaceuticals, INC. | $39.77 | 2024 | Nuzyra |
| Convatec INC. | $36.17 | 2023 | |
| O&M Halyard, INC. | $35.83 | 2020 | |
| Vertex Pharmaceuticals Incorporated | $35.12 | 2024-2025 | |
| Stryker Corporation | $34.37 | 2019 | |
| Kerecis Limited | $27.84 | 2024-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Graftguide |
| Zimmer Biomet Holdings, INC. | $24.73 | 2021 | |
| Integra Lifesciences Corporation | $23.50 | 2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Paladin Technology Solutions | $21.73 | 2024 | |
| Advanced Oxygen Therapy INC. | $17.75 | 2025 | Topical Oxygen Chamber For Extremities |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Wright Medical Technology, INC. | $13.94 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Yagodich listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.